StockWatch
·

Silo Pharma, Inc. Q3 FY25 Results

SILOQ3 FY25 Results
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue0.020.0%0.0%
Total Income0.020.0%0.0%
Expenditure1.177.9%13.6%
PBT-1.117.5%19.4%
Net Profit-1.117.5%19.4%
OPM
NPM
EPS-0.1236.8%45.5%
View full financials

Informational and educational content only. Not investment advice.